ATA Guidelines Tools

Thyroid Disease in Preconception, Pregnancy, and Postpartum

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1545288

Contents of this Issue

Navigation

Page 6 of 53

7 Box 1. Preferred Definitions of Thyroid Function Test Abnormalities During Pregnancy • A laboratory and trimester-specific reference interval is optimally defined as the 2.5th–97.5th percentile range of a population representative of a healthcare provider's patient population that only includes women without major thyroid interfering factors (e.g., TPOAb negative women with a singleton pregnancy, no known thyroid disease, and no [regional] severe iodine deficiency). • Various other factors that may be associated with higher mean TSH and free thyroxine FT4 concentrations (e.g., comorbidities, assisted reproductive technolog y, or thyroglobulin antibody [TgAb] positivity) have not been shown to substantially change the reference interval limits for TSH or FT4 during pregnancy. However, removal of additional cases from a study population could impact the quality of the reference intervals by lowering the number of included individuals. Thus, it does not seem necessary to use these additional exclusion criteria. • Thyroid dysfunction during pregnancy is defined as follows: ▶ Overt primary hypothyroidism: increased (>96.5th percentile) TSH concentration with a decreased (<2.5th percentile) FT4 concentration. ▶ Subclinical hypothyroidism: increased TSH concentration with a normal (2.5th–97.5th percentile) FT concentration. ▶ Isolated maternal hypothyroxinemia: decreased FT4 concentration with a normal concentration. ▶ Overt hyperthyroidism: decreased TSH concentration with elevated FT4 and/or (F)T3 concentration. ▶ Subclinical hyperthyroidism: decreased TSH concentration with normal FT4 and (F)T3 concentration.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease in Preconception, Pregnancy, and Postpartum